Early stages of tumor growth were marked by robust T cell activation, including expression of cytotoxic mediators such as PRF1, GZMB, and IFN-γ, and dynamic polarization supported by IL-12 and STAT4. This evidence concerns the gene PRF1 and neoplasm.